Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Status: Unknown status Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20085
20091
20102
20111
20142
20154
20167
20177
20187
20192
20204
202112
20228
20237

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3
Jiangsu Hansoh Pharmaceutical Co., Ltd.2
National Cancer Center, Korea2
National University Hospital, Singapore2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2
RedCloud Bio2
Shanghai EpimAb Biotherapeutics Co., Ltd.2
Shanghai Gopherwood Biotech Co., Ltd.2
Shanghai Henlius Biotech2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung73
Lung Neoplasms8
Carcinoma, Hepatocellular6
Colorectal Neoplasms6
Melanoma6
Carcinoma, Renal Cell5
Stomach Neoplasms5
Pancreatic Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Mesothelioma3

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.